[1] Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
[2] Hauzeur JP, Gangji V. Phases 1-3 clinical trials using adult stem cells in osteonecrosis and nonunion fractures. Stem Cells Int. 2010;2010:410170.
[3] Tzaribachev N, Vaegler M, Schaefer J, et al. Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis. Isr Med Assoc J. 2008;10(3):232-234.
[4] Tevlin R, Walmsley GG, Marecic O, et al. Stem and progenitor cells: advancing bone tissue engineering. Drug Deliv Transl Res. 2016;6(2):159-173.
[5] Maxson S, Lopez EA, Yoo D, et al. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med. 2012;1(2):142-149.
[6] 朱鸿飞,郑军,徐小燕,等. 不同浓度淫羊藿苷修复骨损伤: 争议与探索[J].中国组织工程研究, 2014, 18(2): 301-306.
[7] Zhang X, Liu T, Huang Y, et al. Icariin: does it have an osteoinductive potential for bone tissue engineering. Phytother Res. 2014;28(4):498-509.
[8] Hsieh TP, Sheu SY, Sun JS, et al. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. Phytomedicine. 2011;18(2-3): 176-185.
[9] Zhai YK, Guo XY, Ge BF, et al. Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K-AKT-eNOS-NO-cGMP- PKG.Bone. 2014;66:189-198.
[10] Bian Q, Huang JH, Liu SF, et al. Different molecular targets of Icariin on bMSCs in CORT and OVX -rats. Front Biosci (Elite Ed). 2012;4:1224-1236.
[11] Nian H, Ma MH, Nian SS, et al. Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine. 2009;16(4):320-326.
[12] Peng S, Zhang G, He Y, et al. Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone. 2009;45(3):534-544.
[13] Li XF, Xu H, Zhao YJ, et al. Icariin Augments Bone Formation and Reverses the Phenotypes of Osteoprotegerin-Deficient Mice through the Activation of Wnt/ β -Catenin-BMP Signaling. Evid Based Complement Alternat Med. 2013;2013:652317.
[14] Fan JJ, Cao LG, Wu T, et al. The dose-effect of icariin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cells. Molecules. 2011;16(12):10123-10133.
[15] Song L, Zhao J, Zhang X, et al. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation.Eur J Pharmacol. 2013;714(1-3):15-22.
[16] Li D, Yuan T, Zhang X, et al. Icariin: a potential promoting compound for cartilage tissue engineering. Osteoarthritis Cartilage. 2012;20(12):1647-1656.
[17] Li GW, Xu Z, Chang SX, et al. Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis. Menopause. 2014;21(9):1007-1016.
[18] Cao H, Ke Y, Zhang Y, et al. Icariin stimulates MC3T3-E1 cell proliferation and differentiation through up-regulation of bone morphogenetic protein-2. Int J Mol Med. 2012;29(3):435-439.
[19] Qin S, Zhou W, Liu S, et al. Icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling. Int J Clin Exp Med. 2015;8(5):7125-7133.
[20] Zheng D, Peng S, Yang SH, et al. The beneficial effect of Icariin on bone is diminished in osteoprotegerin- deficient mice. Bone. 2012;51(1):85-92.
[21] Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89(5):747-754.
[22] Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130(3): 456-469.
[23] Ma HP, Ming LG, Ge BF, et al. Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem. 2011;112(3): 916-923.
[24] Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108(1):17-29.
[25] Nakashima K, de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet. 2003;19(8):458-466.
[26] Huang L, Teng XY, Cheng YY, et al. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone. Bone. 2004;34(3):393-401.
[27] Sen B, Xie Z, Uzer G, et al. Intranuclear Actin Regulates Osteogenesis. Stem Cells. 2015;33(10): 3065-3076.
[28] Ma XN, Zhou J, Ge BF, et al. Icariin induces osteoblast differentiation and mineralization without dexamethasone in vitro. Planta Med. 2013;79(16): 1501-1508.
[29] Langer R. Perspectives and challenges in tissue engineering and regenerative medicine. Adv Mater. 2009;21(32-33):3235-3236.
[30] Garrison KR, Shemilt I, Donell S, et al. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev. 2010;(6): CD006950.
[31] Schmidmaier G, Capanna R, Wildemann B, et al. Bone morphogenetic proteins in critical-size bone defects: what are the options. Injury. 2009;40 Suppl 3:S39-43.
[32] Wang J, Zheng Y, Zhao J, et al. Low-dose rhBMP2/7 heterodimer to reconstruct peri-implant bone defects: a micro-CT evaluation. J Clin Periodontol. 2012;39(1): 98-105.
[33] Kao DW, Kubota A, Nevins M, et al. The negative effect of combining rhBMP-2 and Bio-Oss on bone formation for maxillary sinus augmentation. Int J Periodontics Restorative Dent. 2012;32(1):61-67.
[34] Zhao J, Ohba S, Komiyama Y, et al. Icariin: a potential osteoinductive compound for bone tissue engineering. Tissue Eng Part A. 2010;16(1):233-243. |